Literature DB >> 14643564

The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients.

G Ponce1, M A Jimenez-Arriero, G Rubio, J Hoenicka, I Ampuero, J A Ramos, T Palomo.   

Abstract

BACKGROUND: Presence of A1 allele of the DRD2 gene has been associated with a predisposition for alcoholism although there are limited data about its phenotypic expression in alcoholism.
OBJECTIVES: To determine the importance of the A1 allele in clinical variables of alcohol dependence.
METHODOLOGY: A sample of 103 alcohol-dependent males was studied. All patients were recruited consecutively from the general hospital and community settings. The diagnostics were made with the structured clinical interview for DSM-III-R (SCID); and the International Personality Disorder Examination (IPDE). Diagnosis of family alcoholism was made by direct interview or with the Research Diagnostic Criteria-Family History (RDC-FH). The Addiction Severity Index (ASI) and the Severity of Alcohol Dependence Scale (SADS) were used to assess alcohol dependence severity. Genotyping was done by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods.
RESULTS: Approximately 39% of the sample carried the A1 allele (A1+ group). This group had higher prevalences of antisocial personality disorder (60% vs. 15.9%); and alcoholism family history (72.5% vs. 52.4%). Also A1+ had early onset alcohol abuse and more drinking problems. The presence of A1+ was the main factor to explain the diagnosis of antisocial personality disorder, but the weight of this factor was not sufficient to explain the complications assessed by the ASI.
CONCLUSIONS: Our results support the existence of an association between the A1 allele and factors resulting from dopaminergic deficiency, otherwise denominated reward deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643564     DOI: 10.1016/j.eurpsy.2003.06.006

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  36 in total

Review 1.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Personality traits of agreeableness and extraversion are associated with ADH4 variation.

Authors:  Xingguang Luo; Henry R Kranzler; Lingjun Zuo; Shuang Wang; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2006-10-25       Impact factor: 13.382

Review 3.  From dopaminergic genes to psychiatric disorders.

Authors:  Janet Hoenicka; María Aragüés; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel A Jiménez-Arriero; Tomás Palomo
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

Review 4.  Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.

Authors:  Lars Oreland; Gianvito Lagravinese; Simone Toffoletto; Kent W Nilsson; Jaanus Harro; C Robert Cloninger; Erika Comasco
Journal:  J Neural Transm (Vienna)       Date:  2017-01-04       Impact factor: 3.575

5.  Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injury.

Authors:  John K Yue; Angela M Pronger; Adam R Ferguson; Nancy R Temkin; Sourabh Sharma; Jonathan Rosand; Marco D Sorani; Thomas W McAllister; Jason Barber; Ethan A Winkler; Esteban G Burchard; Donglei Hu; Hester F Lingsma; Shelly R Cooper; Ava M Puccio; David O Okonkwo; Ramon Diaz-Arrastia; Geoffrey T Manley
Journal:  Neurogenetics       Date:  2015-01-30       Impact factor: 2.660

6.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

7.  Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Authors:  Kenneth Blum; Thomas J H Chen; John Bailey; Abdalla Bowirrat; John Femino; Amanda L C Chen; Thomas Simpatico; Siobhan Morse; John Giordano; Uma Damle; Mallory Kerner; Eric R Braverman; Frank Fornari; B William Downs; Cynthia Rector; Debmayla Barh; Marlene Oscar-Berman
Journal:  Mol Neurobiol       Date:  2011-09-24       Impact factor: 5.590

8.  Impulsivity and sustained attention in pathological gamblers: influence of childhood ADHD history.

Authors:  R Rodriguez-Jimenez; C Avila; M A Jimenez-Arriero; G Ponce; R Monasor; M Jimenez; M Aragües; J Hoenicka; G Rubio; T Palomo
Journal:  J Gambl Stud       Date:  2006-12

Review 9.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 10.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.